Fifth Third Bancorp
SGMO

Fifth Third Bancorp’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Fifth Third Bancorp’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,000
Closed -$12K – 2740
2021
Q2 		$12K Buy
1,000
+900
+900% +$10.2K ﹤0.01% 1962
2021
Q1 		$1K Hold
100
– – ﹤0.01% 2380
2020
Q4 		$2K Hold
100
– – ﹤0.01% 2244
2020
Q3 		$1K Hold
100
– – ﹤0.01% 2208
2020
Q2 		$1K Hold
100
– – ﹤0.01% 2040
2020
Q1 		$1K Buy
+100
New +$742 ﹤0.01% 2068
2017
Q2 		– Sell
-400
Closed -$2K – 2257
2017
Q1 		$2K Hold
400
– – ﹤0.01% 2000
2016
Q4 		$1K Hold
400
– – ﹤0.01% 2141
2016
Q3 		$2K Hold
400
– – ﹤0.01% 2111
2016
Q2 		$2K Sell
400
-50
-11% -$319 ﹤0.01% 2131
2016
Q1 		$3K Buy
450
+50
+13% +$300 ﹤0.01% 2107
2015
Q4 		$4K Hold
400
– – ﹤0.01% 2281
2015
Q3 		$2K Hold
400
– – ﹤0.01% 2629
2015
Q2 		$4K Hold
400
– – ﹤0.01% 2378
2015
Q1 		$6K Hold
400
– – ﹤0.01% 2175
2014
Q4 		$6K Hold
400
– – ﹤0.01% 2085
2014
Q3 		$4K Hold
400
– – ﹤0.01% 2199
2014
Q2 		$6K Hold
400
– – ﹤0.01% 2142
2014
Q1 		$7K Buy
+400
New +$7.71K ﹤0.01% 2067

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fifth Third Bancorp's SGMO Position: Q3 2021 in Review

Fifth Third Bancorp sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2021, closing a stake of 1,000 shares — an estimated $12K sold.

Fifth Third Bancorp first reported a position in SGMO in Q1 2014 and held it in 19 quarters. The position peaked at $12K in Q2 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q3 2021.

  • Fifth Third Bancorp reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 1,000 SANGAMO THERAPEUTICS INC shares in Q3 2021, an estimated $12K.
  • Fifth Third Bancorp first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and held it in 19 quarters.
  • Fifth Third Bancorp's SANGAMO THERAPEUTICS INC position peaked at $12K in Q2 2021.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2021.

Based on Fifth Third Bancorp's 13F filing for Q3 2021, filed 15 Oct 2021.